← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 15, 2020Last known activity
Dec 15, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (29 distinct, 21 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (9 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Recent trials (30)
- NCT07254416CollaboratorPhase 4Dec 15, 2025
- NCT06850285Lead sponsorN/ASep 5, 2025
- NCT06850285OfficialN/ASep 5, 2025
- NCT07108530Lead sponsorPhase 2Aug 6, 2025
- NCT07048353CollaboratorEarly Phase 1Jul 28, 2025
- NCT07059156Lead sponsorPhase 2/Phase 3Jun 1, 2025
- NCT06678451OfficialN/ADec 31, 2024
- NCT06678451Lead sponsorN/ADec 31, 2024
- NCT06202625CollaboratorPhase 2/Phase 3May 13, 2024
- NCT06243159Lead sponsorEarly Phase 1Feb 8, 2024
- NCT06243159OfficialEarly Phase 1Feb 8, 2024
- NCT06783816Lead sponsorN/ADec 1, 2023
- NCT05998759OfficialPhase 2Oct 31, 2023
- NCT05998759CollaboratorPhase 2Oct 31, 2023
- NCT05998759Overall official - principal investigatorPhase 2Oct 31, 2023
Details
- Last known activity
- Dec 15, 2025